1.A Case of Chronic Atrial Tachycardia Managed with Digoxin and Reserpine.
Young Hee KIM ; Young Ju CHOI ; Sang Il RHEE ; Sang Woo KIM
Journal of the Korean Pediatric Society 1984;27(1):79-83
No abstract available.
Digoxin*
;
Reserpine*
;
Tachycardia*
2.Development of diagnostic method of helicobacter pylori infection: I. molecular cloning and DNA sequencing of urease.
Cheol Keun PARK ; Woo Kon LEE ; Young Mi DOH ; Myung Je CHO ; Kwang Ho RHEE
Journal of the Korean Society for Microbiology 1991;26(6):541-552
No abstract available.
Cloning, Molecular*
;
DNA*
;
Helicobacter pylori*
;
Helicobacter*
;
Sequence Analysis, DNA*
;
Urease*
3.Studies on the infectivity of rickettsia tsutsugamushi in bird.
Young Woo SHIN ; Ho Yeon SONG ; Kwang Kjune KO ; Kang Soon RHEE
Journal of the Korean Society for Microbiology 1991;26(2):185-194
No abstract available.
Birds*
;
Orientia tsutsugamushi*
;
Rickettsia*
4.Popliteal pterygium syndrome: A Case Report
Kwang Jin RHEE ; Jun Kyu LEE ; Chan Hee PARK ; Young Gil WOO ; Sang Yong LEE
The Journal of the Korean Orthopaedic Association 1996;31(2):352-356
Popliteal pterygium syndrome is rare, with 60 cases described in the literature. The syndrome includes a popliteal web extending from the ischium to the heel and other abnormalities including toenail dysplasia, deformities of the foot and toes, and oral cavity abnormalities. The main orthopedic problem is a flextion contracture of the knee and an equinus foot. We experienced a six-month-old girl with popliteal pterygium, in whom resection of abnormal fibrotic muscle belly, Achilles tendon legnthening, and Z-plastic lengthening of the skin resulted in partial correction of flexion deformity of the knee and equines contracture of the foot at one year follow-up.
Achilles Tendon
;
Congenital Abnormalities
;
Contracture
;
Female
;
Follow-Up Studies
;
Foot
;
Heel
;
Humans
;
Ischium
;
Knee
;
Mouth
;
Nails
;
Orthopedics
;
Pterygium
;
Skin
;
Toes
5.A radiologic evaluation of fit of noncemented prosthetic femoral stems.
Myung Chul YOO ; Yong Girl RHEE ; Young Woo KIM ; Jong Jin KIM ; Yong Jae KIM
The Journal of the Korean Orthopaedic Association 1993;28(1):1-10
No abstract available.
6.Growth Changes of Lower Extremities after Pyogenic or Tuberculous Knee Joints in Children.
Seung Koo RHEE ; Young Kyun WOO ; Yong Sik KIM ; Ki Won KIM ; Hyo Seung AHN
The Journal of the Korean Orthopaedic Association 1998;33(2):335-342
It is well-known that the infection of bone and joints could produce the shortening by destroying the articuiar cartilage and growth plate, or the lengthening hy increased hlood circulation to the epiphyseal and metaphyseal regions of long bone. Since 1985, we have treated total l7 cases of children s pyogenic or tuberculous children s knee with early arthrotomy and continuous irrigation etc. and followed their long hone growth for average 53 months after surgical intervention. Five patients (group I ) were early treated within 2 weeks and twelve patients(group 3 ) were delayed to treat their knees for more than 2 weeks of symptom development. Total 11 patients out of 17 cases(64.7%) (2 cases of group 1 pyogenic arthritis, and 1 case of group l and 8 cases of group II tuberculous arthritis) revealed growth acceleration. Femoral lengthening was much more greater than that of tibial growth, and the size of patella, distal femoral and proximal tibial epiphysis which were measured by computerized digitizer were also significantly larger than that of opposite knee. The total limb length was increased hy average 7mm in 6 months, l4mm in 1 year and 3mm in 2 years after operation. These results suggest the pyogenic and tuberculous arthritis in children s knee should he treated as early as possible after symptoms developed, and followed them to trace their limh inequality for at least 2 years after surgery. That means the early arthrotomy for tuberculous knee or even in pyogenic arthritis can preserve normal articular cartilage and can also prevent the early epiphyseal closure hy infection. and can get the limh lengthening by increased blood circulation around the knee joint.
Acceleration
;
Arthritis
;
Blood Circulation
;
Cartilage
;
Cartilage, Articular
;
Child*
;
Epiphyses
;
Extremities
;
Growth Plate
;
Humans
;
Joints
;
Knee Joint*
;
Knee*
;
Lower Extremity*
;
Patella
;
Socioeconomic Factors
7.Postoperative Intubation Time in Patients Undergoing Open Heart Surgery.
Ka Young RHEE ; Yun Seok JEON ; Woo Sik EOM ; Sang Hwan DO ; Chong Soo KIM ; Kwang Woo KIM
Korean Journal of Anesthesiology 1997;33(4):660-663
BACKGROUND: Cardiac patients undergoing open heart surgery usually require ventilatory support that involves ICU admission in the postoperative period. We tried to find out determinants of postoperative ventilatory support time. METHODS: We reviewed the medical records of 56 open heart surgery patients retrospectively in terms of their disease, preoperative physical status, age, post-bypass arterial oxygen tension/inspired oxygen fraction (PaO2/FIO2) ratio, number of inotropics used and searched the relationship between each factor and postoperative intubation time. RESULTS: None of the factors except the number of inotropics used had an significant influence on the postoperative intubation time. CONCLUSION: In open heart surgical patients their disease, preoperative physical status, age, postbypass PaO2/FIO2 ratio do not affect postoperative intubation time rather than number of inotropics used does.
Heart*
;
Humans
;
Intubation*
;
Medical Records
;
Oxygen
;
Postoperative Period
;
Retrospective Studies
;
Thoracic Surgery*
8.Phase 2 Trial of FLP ( 5-FU , Leucovorin , Cisplatin ) Combination Chemotherapy for Advanced Gastric Cancer.
Young Iee PARK ; Moon Hee LEE ; Sung Woo HAN ; Woo Jung PARK ; Dong Gyu KIM ; Jin LEE ; Jin Seok AHN ; Jung Ae RHEE ; In Sook WOO ; Young Suk PARK
Journal of the Korean Cancer Association 1998;30(1):55-62
PURPOSE: Advanced gastric cancer, the most common malignancy in Korea is a kind of systemic disease. At dignosis, 50~80% of patients have systemic cancer. Therefore, the most patients require systemic chemotherapy. Cisplatin and 5-FU have been suggested to be active in the treatment of gastric cancer, a high response rate was observered with a combination of 5-FU infusion and cisplatin, and the biochemical modulation of 5-FU by leucovorin has been demonstrated to enhance the activity of 5-FU in gastrointestinal tract cancer. MATERIALS AND METHODS: The patients with advanced gastric cancer whose disease had relapsed or unresectable were treated with 5-FU(800 mg/m2 12 hr IV infusion, D 1~5), leucovorin(20 mg/m2 IV, D 1~5, max. 30 mg), cisplatin(100 mg/m2 15min IV dripping, D1). The cycles of treatment were repeated at 3-weeks intervals. RESULTS: Between Sep. 1994 and Aug. 1996, previously untreated 44 patients(39 eligible patients) were admitted to this study, the median age was 55 years(range 17~73) and male to female ratio was 20:19. The rate of complete remission was 5%(2/39), the rate of partial remission was 21%(8/39). The median-response duration was 26 weeks(5+~38+ ). The median-time to progression was 25 weeks(4+~62+). The range of overall survival time was from 4 to 62+ weeks. 24 weeks survival rate was 71.5% but the median survival time was not reached. The leukopenia and anemia were the main hematologic toxicities. Non-hematologic side effects were nausea, vomiting, diarrhea, stomatitis, peripheral neuropathy. These toxicities were observed commnonly, but tolerable. Two treatment-related deaths were associated with sepsis. CONCLUSION: Based on these results, FLP combination chemotherapy seems to be a moderate efficacy for advanced gastric cancer with tolerable toxicities. To confirm the efficacy further, the long-term follow up and a large scale of clinical studies are needed.
Anemia
;
Cisplatin*
;
Diarrhea
;
Drug Therapy
;
Drug Therapy, Combination*
;
Female
;
Fluorouracil*
;
Follow-Up Studies
;
Gastrointestinal Neoplasms
;
Humans
;
Korea
;
Leucovorin*
;
Leukopenia
;
Male
;
Nausea
;
Peripheral Nervous System Diseases
;
Sepsis
;
Stomach Neoplasms*
;
Stomatitis
;
Survival Rate
;
Vomiting
9.A clinical analysis of ectopic pregnancy.
Jeong Ho RHEE ; Eung Chul CHOI ; Ji Young LEE ; Yeon Jung YOON ; Shin Ae LEE ; Jong Woo KIM
Korean Journal of Obstetrics and Gynecology 1991;34(7):972-983
No abstract available.
Female
;
Pregnancy
;
Pregnancy, Ectopic*
10.Effects of Dihydrochlorothiazide, Propranolol, and Prazosin on Serum Lipids in Patients with Essential Hypertension.
Seung Bum JIN ; Young Woo RHEE ; Seok Won CHANG ; Ki Cheol KIM ; Soek Pil KIM ; Chang Sup SONG
Korean Circulation Journal 1985;15(2):329-336
Three groups of patients with newely diagnosed hypertension, or with hypertension not optimally controlled by previous treatment, completed a comparative study on the effects of Dihydrochlorothiazide, propranolol, and prazosin on plasma lipids after three months therapy. The drugs showed equipotent antihypertensive effects(P<0.01). Dihydrochlorothiazide administration was associated with a significant elevation of total cholesterol(42%, P<0.05), and triglyceride(8.1%, P<0.01). Changes of HDL-C(5.1%), LDL-C(3.3%), and cholesterol ratio(-4.8%) were not significant. Propranolol administration was associated with significant elevation of total cholesterol(3.8%, P<0.05), triglyceride(14.5%, P<0.005), and LDL-C(5.6%, P<0.005). Reduction of HDL-C(-7.8%, P<0.05) and cholesterol ratio(-14.7%, p<0.005) was also statistically significant. Prazosin administration was associated with significant decrease in total cholesterol(-6.6%, P<0.005), triglycride(-9.6%, P<0.005), and LDL-C(-11.7%, P<0.005), and significant elevation of HDL-C(10.6%,P<0.005) and cholesterol ratio(24.2%, P<0.005) was noted.
Cholesterol
;
Humans
;
Hydrochlorothiazide*
;
Hypertension*
;
Plasma
;
Prazosin*
;
Propranolol*